Filing Details
- Accession Number:
- 0001104659-20-080552
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-07-02 16:13:40
- Reporting Period:
- 2020-07-01
- Accepted Time:
- 2020-07-02 16:13:40
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1730430 | Kiniksa Pharmaceuticals Ltd. | KNSA | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1741382 | W. Thomas Beetham | C/O Kiniksa Pharmaceuticals, Ltd. Clarendon House 2 Church Street Hamilton D0 HM11 | Evp & Chief Legal Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class A Common Shares | Disposition | 2020-07-01 | 26,734 | $25.32 | 2,855 | No | 4 | S | Direct | |
| Class A Common Shares | Disposition | 2020-07-01 | 2,855 | $25.84 | 0 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1plan executed by the reporting person on December 24, 2019.
- This transaction was executed in multiple trades through a broker-dealer at prices ranging from $24.77 to $25.74. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price
- This transaction was executed in multiple trades through a broker-dealer at prices ranging from $25.78 to $25.99. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of Shares sold at each price
Billionaire Hedge Funds
